Cilt Nefes Alır Miti: Oklude Ediciler Hakkındaki Yanlış Bilgiler

The "Skin Needs to Breathe" Myth: Correcting Misinformation About Occlusive Ingredients

The claim that occlusive ingredients "suffocate" skin by blocking its ability to "breathe" reflects a fundamental misunderstanding of cutaneous oxygen physiology, directly contradicted by research on how skin actually obtains oxygen.

Key Findings

  • Stücker et al.'s research specifically documented that cutaneous atmospheric oxygen uptake contributes significantly to dermal and epidermal oxygen supply, providing direct physiological data relevant to this myth.[2]
  • The primary source of cutaneous oxygen supply is dermal blood circulation, not direct atmospheric absorption through pores in the way the "breathing" framing implies.[6]
  • Fiume et al.'s comprehensive safety assessment of petrolatum, the most studied occlusive ingredient, documents extensive safety data without evidence supporting the suffocation concern.[5]
  • Simpson et al.'s randomized controlled trial demonstrating emollient-based atopic dermatitis prevention provides direct evidence against any clinically meaningful "suffocation" harm from occlusive use.[4]

How Skin Actually Obtains Oxygen

Elias and Feingold's comprehensive skin barrier reference work establishes that the skin's primary oxygen supply derives from dermal blood circulation, delivered via the extensive dermal vasculature, rather than through direct, pore-mediated atmospheric absorption in the way the "skin needs to breathe" framing implies.[6] This circulatory oxygen delivery mechanism operates independently of whatever topical product is applied to the skin surface.

The "Skin Needs to Breathe" Myth: Correcting Misinformation About Occlusive Ingredients | CIRÈLL
The "Skin Needs to Breathe" Myth: Correcting Misinformation About Occlusive Ingredients

Documented Atmospheric Contribution — And Its Limits

Stücker et al.'s specific research did find that cutaneous atmospheric oxygen uptake contributes meaningfully to dermal and epidermal oxygen supply, a genuinely interesting physiological finding — but this atmospheric contribution operates as a supplementary pathway alongside, not instead of, the dominant circulatory supply, and the research does not support the claim that temporarily occluding the skin surface with a topical product produces clinically meaningful oxygen deprivation given the circulatory system's continued, unaffected function.[2]

The Occlusive Mechanism Does Not Block Circulation

Elias's stratum corneum defensive functions research clarifies that occlusive topical agents (petrolatum, dimethicone) function by reducing water vapor transit through the outermost stratum corneum layer — they do not affect dermal blood circulation, the actual primary oxygen delivery mechanism, meaning the "suffocation" framing conflates surface-level water vapor occlusion with a physiologically unrelated oxygen-delivery concern.[1]

Extensive Safety Data on the Most-Studied Occlusive

Fiume et al.'s comprehensive toxicological safety assessment of petrolatum — among the most extensively studied occlusive ingredients in cosmetic use — documents no evidence supporting a suffocation or oxygen-deprivation safety concern across decades of use and research, providing strong indirect evidence against the myth through the absence of any such documented adverse finding despite extensive scrutiny.[5]

Clinical Trial Evidence Against Harm

Simpson et al.'s randomized controlled trial finding that emollient-based (including occlusive-containing) barrier enhancement from birth significantly reduced atopic dermatitis incidence in high-risk infants provides particularly strong evidence against any clinically meaningful suffocation harm: if occlusive use genuinely compromised skin oxygenation or health, this would be expected to manifest as adverse outcomes in a large randomized trial population, which was not observed — instead, the trial found clear benefit.[4]

Clinical Trial Evidence Against Harm | CIRÈLL
Clinical Trial Evidence Against Harm

Conclusion

The "skin needs to breathe" concern about occlusive ingredients reflects a fundamental misunderstanding of cutaneous oxygen physiology — the dominant oxygen supply comes from dermal circulation, unaffected by surface occlusion, and extensive safety data plus randomized clinical trial evidence directly contradict any suffocation-related harm from appropriate occlusive use. For guidance on occlusive ingredient use in your routine, our pharmacist, Mine Ekber, is available for direct consultation via WhatsApp.

Frequently Asked Questions

Do occlusive ingredients like petrolatum actually block skin from getting oxygen?

No — the skin's primary oxygen supply comes from dermal blood circulation, which is unaffected by surface occlusion; occlusive ingredients reduce water vapor loss through the outer stratum corneum, a mechanism unrelated to oxygen delivery.

Is there any real evidence behind the "skin needs to breathe" concern?

No — extensive toxicological safety assessment of petrolatum, one of the most studied occlusive ingredients, documents no suffocation-related safety concern, and randomized clinical trials of occlusive-containing emollients have found clear benefit, not harm.

Does skin absorb any oxygen directly from the air?

Research has found that atmospheric oxygen uptake does contribute to dermal and epidermal oxygen supply, but as a supplementary pathway alongside, not instead of, the dominant circulatory oxygen delivery mechanism.

References

  1. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125(2):183-200.
  2. Stücker M, Struk A, Altmeyer P, Herde M, Baumgärtl H, Lübbers DW. The cutaneous uptake of atmospheric oxygen contributes significantly to the oxygen supply of human dermis and epidermis. J Physiol. 2002;538(Pt 3):985-994.
  3. Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther. 2004;17(Suppl 1):43-48.
  4. Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134(4):818-823.
  5. Fiume MM, Bergfeld WF, Belsito DV, et al. Safety Assessment of Petrolatum as Used in Cosmetics. Int J Toxicol. 2015;34(3 Suppl):3S-23S.
  6. Elias PM, Feingold KR. Skin Barrier: From Basic Science to Therapeutic Strategies. Taylor & Francis; 2006.
  7. Baumann L. Skin ageing and its treatment. J Pathol. 2007;211(2):241-251.

Further Reading

Back to blog

Leave a comment